Massachusetts Institute of Technology (MIT) find helps Dyax target cancer tumours
This article was originally published in Clinica
Executive Summary
A technique which enables the discovery of previously unknown proteins associated with disease or tumour cells has been obtained by Dyax under licence from the Massachusetts Institute of Technology.